astrazeneca plc news - Search News

AstraZeneca, China

AstraZeneca Falls Most Since 2020 as China Probe Fears Mount

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker.

Reuters on MSN · 4d

AstraZeneca's China chief in custody, believes unrelated to insurance probe

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason, it did not believe it was linked to a large health insurance fraud case involving the company.

KTBS · 3d

Pharma giant AstraZeneca says China chief detained

Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the firm was under investigation for potentially illegal data collection and drug imports.

Bloomberg L.P. · 4d

AstraZeneca Says Current, Former Executives Involved in China Probe

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe into alleged breaches of laws around drug importation and data privacy, the company said.

Hosted on MSN12h

Is AstraZeneca PLC (AZN) The Best UK Stock to Invest in Now?

We recently compiled a list of the 10 Best UK Stocks to Invest in Now. In this article, we are going to take a look at where ...

AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off

AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it ...

6don MSN

AstraZeneca Unveils Early Data From Chinese-Firm Partnered Oral Weight Loss Drug

At the ObesityWeek 2024, AstraZeneca Plc (NASDAQ:AZN) shared data abstracts highlighting early data from AZD5004/ECC5004. In ...

MarketWatch6d

AstraZeneca PLC ADR rises Monday, outperforms market

The AstraZeneca PLC ADR AZN inched 0.01% higher to $71.43 Monday, on what proved to be an all-around grim trading session ...

AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

10d

China Widens AstraZeneca Probe as Country Boss Investigated

AstraZeneca Plc’s China President Leon Wang is under investigation by Chinese authorities, the drugmaker said Wednesday.

Morningstar3d

AstraZeneca PLC ADR AZN

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca touts positive results from nasal polyp treatment study

AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...

devdiscourse5d

AstraZeneca's Unwavering Commitment Amidst Challenges

AstraZeneca PLC, maintaining its operations in China, remains steadfast amidst speculative media scrutiny concerning ongoing ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results